ENTITY
Zylox-Tonbridge Medical Technology

Zylox-Tonbridge Medical Technology (2190 HK)

44
Analysis
Health CareChina
Leading player in the neuro- and peripheral-vascular interventional medical device market in China.
more
12 Aug 2024 09:15

Zylox-Tonbridge Medical Technology (2190.HK) - A Good Alpha-Generating Opportunity for Investors

​Zylox's strong fundamentals and growth potential have not been fully reflected in current valuation due to market conditions, making it a...

Logo
249 Views
Share
27 Apr 2021 07:29

Pre-IPO Zylox-Tonbridge Medical Technology - Promising Market with Challenges

This insights analyzed Zylox-Tonbridge Medical Technology in terms of the market potential, industry characteristics, business analysis, financial...

Logo
393 Views
Share
24 Jun 2024 08:55

Acotec Scientific Holdings (6669.HK) - The Company Is Now In Trouble

Acotec’s 2023 results were disappointing due to VBP and anti-corruption campaign. Growth of core products declined significantly and the...

Logo
343 Views
Share
21 May 2023 09:29

China Healthcare Weekly (May.19) - "Hedge Logic" Of CXO, Beijing's DRG+VBP Policy, Zylox-Tonbridge

Beijing issued new VBP+DRG policy for sports medicine/neurointervention/electrophysiology. CXO's "hedge logic" doesn't guarantee the whole industry...

Logo
348 Views
Share
15 May 2023 08:55

Acotec Scientific (6669.HK) - What Value Boston Scientific Will Bring Is Crucial to Future Valuation

There're many highlights in Acotec’s performance last year,but growth ceiling is obvious if rely solely on China market.Boston Scientific's...

Logo
351 Views
Share
x